Clinical Microbiology and Infection

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	970
COVID-19, SARS and MERS: are they closely related?	752
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	564
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	526
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	488
Follow-up of adults with noncritical COVID-19 two months after symptom onset	484
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	463
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	448
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	423
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	412
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	314
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	279
Novel SARS-CoV-2 variants: the pandemics within the pandemic	265
COVID-19 pandemic—a focused review for clinicians	258
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	258
COVID-19: don't neglect antimicrobial stewardship principles!	244
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	243
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	242
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	232
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	231
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	222
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	217
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	214
Female gender is associated with long COVID syndrome: a prospective cohort study	206
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	205

Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	201
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	198
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	197
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	188
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	187
Viable SARS-CoV-2 in various specimens from COVID-19 patients	174
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	166
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	165
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	155
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	154
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	145
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	142
Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis	142
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	138
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	137
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	131
Validation of a commercially available SARS-CoV-2 serological immunoassay	130
Pathogenesis and management of fracture-related infection	129
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	125
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	123
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	119
Post–COVID-19 chronic symptoms: a postinfectious entity?	117
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	116
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	114
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	114
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	114
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	114
Anosmia in COVID-19 patients	112
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	111
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	108
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	102
Ibuprofen use and clinical outcomes in COVID-19 patients	100
Understanding the role of bacterial and fungal infection in COVID-19	100
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	99
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	98
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	98
ESCMID COVID-19 living guidelines: drug treatment and clinical management	98
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	97
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	95
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	92
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	91
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	91
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study	91
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	90
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	90
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	90
Stigma at the time of the COVID-19 pandemic	90
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	90
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	88
How to interpret and use COVID-19 serology and immunology tests	87

The interface between COVID-19 and bacterial healthcare-associated infections	87
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	87
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	86
Clostridium difficile and One Health	85
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	85
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy	84
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	84
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	83
Current landscape in the discovery of novel antibacterial agents	83
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	82
Evolution of viral quasispecies during SARS-CoV-2 infection	82
Commercially available molecular tests for human papillomaviruses: a global overview	81
Neurologic manifestations associated with COVID-19: a multicentre registry	81
Risk factors for chronic biofilm-related infection associated with implanted medical devices	79
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	79
Follow-up of asymptomatic patients with SARS-CoV-2 infection	79
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	78
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	78
How do I manage nocardiosis?	75
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre	75
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	73
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	73
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	73
Review of trials currently testing treatment and prevention of COVID-19	73
Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea	71
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	71
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	70
Excretion of SARS-CoV-2 in human breast milk	70
Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers	69
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	68
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection	66
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	65
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	65
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	65
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	62
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	62
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	61
ESCMID rapid guidelines for assessment and management of long COVID	61
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	60
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital	60
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	60
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	59
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	58
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	58
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	57
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	56
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization	56
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	56
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	56
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	55
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	55
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	54
Corticosteroid administration for viral pneumonia: COVID-19 and beyond	53
Long COVID-19—it's not over until?	52
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)	52
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	52
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	52
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications	52
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	52
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	52
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	51
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	51
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	50
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	50
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum	49
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	49
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	49
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	49
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis	49
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	49
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	49
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	49
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	48
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	48
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	48
Serology anno 2021—fungal infections: from invasive to chronic	48
Novel coronavirus: how things are in Wuhan	47
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	47
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	46
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	46

Culture-independent detection systems for bloodstream infection	46
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	46
Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	46
Invasive aspergillosis in patients with severe COVID-19 pneumonia	46
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	45
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	45
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	45
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019	45
Update on SARS-CoV-2 seroprevalence: regional and worldwide	44
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	43
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19	43
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes	43
Antibiotic use in the COVID-19 crisis in Spain	43
The kinetics of viral load and antibodies to SARS-CoV-2	43
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	42
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	41
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	41
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	41
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	41
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	41
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA	41
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	41
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	40
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review	40
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	40
Co-infection with other respiratory pathogens in COVID-19 patients	40
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	40
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	39
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	39
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	39
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	38
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	38
Image analysis and artificial intelligence in infectious disease diagnostics	38
How to start an antimicrobial stewardship programme in a hospital	38
Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017	37
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	37
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	37
Saliva for molecular detection of SARS-CoV-2 in school-age children	37
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia	36
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	36
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	36
Smartphones as mobile microbiological laboratories	36
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	36
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	36
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity	36
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	35
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	35
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	35
Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial	35
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	35
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	35
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	35
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	35
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper	35
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	35
Microbiology of hip and knee periprosthetic joint infections: a database study	34
Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study	34
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	34
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance	33
Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study	33
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	33
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort	33
Dynamics and predisposition of respiratory viral co-infections in children and adults	33
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	32
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	32
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	32
The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics	32
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae	31
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	31
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	31
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	31
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	31
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?	31
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	31
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	31
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	31
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospec	30
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	30
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis	30
Pretomanid for tuberculosis: a systematic review	30
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	30
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	30
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey	30
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonolog	30
How do I manage a patient with enterococcal bacteraemia?	30
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	30
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries	30
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	30
Aminoglycosides for infective endocarditis: time to say goodbye?	30
An update on Toscana virus distribution, genetics, medical and diagnostic aspects	30
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain	30
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial	30
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	30
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	30
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	30